The University of Southampton
University of Southampton Institutional Repository

Polyphosphate kinase from intracellular pathogens as a novel antibacterial target

Polyphosphate kinase from intracellular pathogens as a novel antibacterial target
Polyphosphate kinase from intracellular pathogens as a novel antibacterial target
To circumvent the established mechanisms of bacterial resistance towards the available antibiotics, previously unexploited pathways critical for bacterial survival and pathogenicity must be targeted. Polyphosphate metabolism plays a crucial role in bacterial survival, in the expression of several virulence factors, in bacterial persistence and in the adaptation to stress conditions. The bacterial enzyme polyphosphate kinase (PPK) catalyses the reversible synthesis of polyphosphate by the transfer of a phosphate unit from ATP onto the growing polyphosphate chain. The presence of PPK in the genome of many pathogens and the attenuation of virulence observed in ppk deletion mutants make the PPK a potential target for the development of a new class of antibiotics.

The objective of this project has been the biochemical characterization of PPK2 from Francisella tularensis (FtPPK), the discovery of potential inhibitors and their evaluation as antibacterial agents. Using recombinant FtPPK and firefly luciferase, a coupled assay was developed to measure the FtPPK activity and further optimised to produce a robust assay in a format suitable for high throughput screening (384 well plate, Z'=0.70). The optimised FtPPK- luciferase coupled assay was used to characterize the kinetic properties of FtPPK and for the screening of two small libraries: a protein kinase inhibitor library (Protein Kinase Inhibitor Set, released by GSK), and a nucleotide analogue library (Reynolds library). The screening yielded 27 and 34 initial hits, respectively. The hits were validated by independent
luminescence assay, thermal shift assay and HPLC assay. The most potent hit was resynthesised for detailed characterization. IC50 and preliminary mode of inhibition have been investigated and, in conjunction with some preliminary SAR and with the modelling in the FtPPK active site, provide a starting point for later medicinal chemistry optimisation.
University of Southampton
Giurrandino, Mariacarmela
12ac7f41-687e-4b55-8142-707a157cf2ca
Giurrandino, Mariacarmela
12ac7f41-687e-4b55-8142-707a157cf2ca
Roach, Peter
ca94060c-4443-482b-af3e-979243488ba9

Giurrandino, Mariacarmela (2017) Polyphosphate kinase from intracellular pathogens as a novel antibacterial target. University of Southampton, Doctoral Thesis, 435pp.

Record type: Thesis (Doctoral)

Abstract

To circumvent the established mechanisms of bacterial resistance towards the available antibiotics, previously unexploited pathways critical for bacterial survival and pathogenicity must be targeted. Polyphosphate metabolism plays a crucial role in bacterial survival, in the expression of several virulence factors, in bacterial persistence and in the adaptation to stress conditions. The bacterial enzyme polyphosphate kinase (PPK) catalyses the reversible synthesis of polyphosphate by the transfer of a phosphate unit from ATP onto the growing polyphosphate chain. The presence of PPK in the genome of many pathogens and the attenuation of virulence observed in ppk deletion mutants make the PPK a potential target for the development of a new class of antibiotics.

The objective of this project has been the biochemical characterization of PPK2 from Francisella tularensis (FtPPK), the discovery of potential inhibitors and their evaluation as antibacterial agents. Using recombinant FtPPK and firefly luciferase, a coupled assay was developed to measure the FtPPK activity and further optimised to produce a robust assay in a format suitable for high throughput screening (384 well plate, Z'=0.70). The optimised FtPPK- luciferase coupled assay was used to characterize the kinetic properties of FtPPK and for the screening of two small libraries: a protein kinase inhibitor library (Protein Kinase Inhibitor Set, released by GSK), and a nucleotide analogue library (Reynolds library). The screening yielded 27 and 34 initial hits, respectively. The hits were validated by independent
luminescence assay, thermal shift assay and HPLC assay. The most potent hit was resynthesised for detailed characterization. IC50 and preliminary mode of inhibition have been investigated and, in conjunction with some preliminary SAR and with the modelling in the FtPPK active site, provide a starting point for later medicinal chemistry optimisation.

Text
M Giurrandino_PhD thesis - Version of Record
Restricted to Repository staff only until 20 November 2020.
Available under License University of Southampton Thesis Licence.

More information

Published date: May 2017

Identifiers

Local EPrints ID: 417923
URI: http://eprints.soton.ac.uk/id/eprint/417923
PURE UUID: baf8d4cc-96ee-42d3-960f-78349083cf9e
ORCID for Peter Roach: ORCID iD orcid.org/0000-0001-9880-2877

Catalogue record

Date deposited: 16 Feb 2018 17:30
Last modified: 14 Mar 2019 01:47

Export record

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×